ReproNovo

Showing 2 posts of 2 posts found.

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026
Research and Development ReproNovo, fertility study

ReproNovo has dosed the first participant in its phase 2 NORDIC study evaluating RPN-002, an investigational therapy designed to improve …

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026
ReproNovo

ReproNovo has appointed Mark Altmeyer as Chairman of the Board of Directors. Bringing over 35 years of experience to the …

The Gateway to Local Adoption Series

Latest content